Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
about
Role of MXD3 in proliferation of DAOY human medulloblastoma cellsSmoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.Therapeutic targets of triple-negative breast cancer: a reviewThe genetic landscape of the childhood cancer medulloblastomaMedulloblastoma exosome proteomics yield functional roles for extracellular vesiclesHepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.Neuroimaging of pediatric posterior fossa tumors including review of the literature.Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors.Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma.Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomasMedulloblastoma subgroups remain stable across primary and metastatic compartments.Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.MXD3 regulation of DAOY cell proliferation dictated by time course of activation.An animal model of MYC-driven medulloblastomaASC deficiency suppresses proliferation and prevents medulloblastoma incidenceThe micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangementFunctional evaluation of therapeutic response for a mouse model of medulloblastomaEpigenetic Silencing of DKK3 in medulloblastoma.Aggressive infantile embryonal tumors.Molecular subgroups of adult medulloblastoma: a long-term single-institution studyHigh-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)Medulloblastoma: from molecular pathology to therapyAntiangiogenic strategies in medulloblastoma: reality or mystery.Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.The rationale for targeted therapies in medulloblastoma.Treatment of posterior fossa tumors in children.Aberrant signaling pathways in medulloblastomas: a stem cell connection.Risk-adapted chemotherapy in childhood medulloblastoma.The adolescent and young adult with cancer: state of the art--brain tumor.Molecular biology of medulloblastoma: bridging the gap between research and practice.The Emerging Molecular Foundations of Pediatric Brain Tumors.Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.Antitumour activity of AMG 900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines.SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.Effect of small nuclear ribonucleoprotein-associated polypeptide N on the proliferation of medulloblastoma cells.MiR-34a deficiency accelerates medulloblastoma formation in vivo.
P2860
Q21090897-0C83277D-30F9-4334-B71D-4ACE3AF6B3FEQ27851485-E45812C0-5FC8-43DD-BB51-23655A6D4E38Q28081591-41F6D22E-78D4-475C-A42F-2E84424196BEQ28301196-186A4B6F-3C6A-4D9D-9425-D05AC3235D45Q28481626-6F0F118E-7371-40F0-8DDC-61511D9E0561Q30851343-E2D64BFC-9304-4B9D-AA20-22E88E49910EQ33407400-7BB45E72-19A5-4E30-98F0-D210C68244EEQ34046892-1ACFAD46-A17A-42AC-BE0B-6508ECCF58A7Q34108929-04FDFF75-8DF3-4DBF-A5CE-B50A2F8D6124Q34134686-6D4CB81A-E218-4E1F-853C-F58F251C469FQ34470472-84AF309F-FD3B-4EB0-9861-C766DBCE6F67Q34474267-C21EF05A-7F9D-4285-B30C-32FA48AB0A41Q35099027-983E2A6C-2A2E-49A9-A5BB-482C685CBA87Q35124738-6980118F-3E33-463F-A017-02AE0AE7BF7FQ35211345-18725D7C-D8C4-49BF-BE82-6BC1C2E7D924Q35774418-B0C72687-08B2-45CF-BE24-882165E97696Q35904348-FE0DECA5-D595-49B0-831A-A89C94065297Q35914487-D859B908-3EE6-4DB6-ACD2-AFF3E8C713C6Q35989886-185F6C30-0135-4ACE-AE3B-B0942FCDB498Q36048155-21F03C60-EFD4-42CC-8321-6A5278089FFAQ36630089-877B16F2-08C5-416E-915C-47C73824213DQ36820466-79F3DD08-B5EC-4002-A56D-299F59136D30Q36907570-6C8CA689-A895-4DC2-BE98-3D87FD7DF797Q36977713-86A9777D-6871-4E09-8B06-8E0A74059ECDQ37066730-8A2BDC6A-62BC-4CD5-A580-4890FB5CCD35Q37087083-F15CA93B-23CB-4D2B-A2EC-6157AF31022CQ37143958-29900162-4863-4A67-A412-D09B3AEAF4C5Q37172731-95E43496-8E75-481A-B262-773A3048C2DAQ37409736-8F68C2D1-7189-4C37-97EC-BF3B75AFBB53Q37724213-A1CB4896-90DE-46CC-8E49-205FABCB0A70Q37829652-EEE7D1CA-06AE-40DC-BCC8-708FED686457Q37873471-6DED3281-B289-4881-916F-7B0DA75AA0BDQ38112071-67DA57A2-9A35-4AFE-985B-F71152B4296DQ38410982-48392468-B20F-4536-9322-AA41D9A7066DQ38421001-E4290330-E45B-4785-86C9-7355EA5177C1Q38817974-8A00521A-6398-4305-8859-4C97EE449CC7Q38872009-662FF327-80E4-4BA3-A60F-8485F9F2E2E1Q38904944-7EF6760D-0100-4B31-BD31-60FCBC049901Q38922081-10DD54AC-3B4F-477B-8AF0-23AFA9AD6789Q38944728-16896FA6-9471-40F9-9641-AD2316B9FCC5
P2860
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@ast
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@en
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@nl
type
label
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@ast
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@en
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@nl
prefLabel
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@ast
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@en
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@nl
P2860
P356
P1476
Medulloblastoma: tumorigenesis ...... to improve risk stratification
@en
P2093
Nancy J Tarbell
William R Polkinghorn
P2860
P304
P356
10.1038/NCPONC0794
P407
P577
2007-05-01T00:00:00Z